Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Net Cash Flow Growth (5y) (2014 - 2026)

Analysis

Quest Diagnostics (DGX) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.63%
Mar 31, 2026 -18.75%
Dec 31, 2025 50.71%
Sep 30, 2025 -28.54%
Jun 30, 2025 -27.77%
Mar 31, 2025 15.69%
Dec 31, 2024 -17.86%
Sep 30, 2024 25.08%
Jun 30, 2024 -1.23%
Mar 31, 2024 -21.47%
Dec 31, 2023 44.23%
Sep 30, 2023 -33.53%
Jun 30, 2023 -52.04%
Mar 31, 2023 -60.86%
Dec 31, 2022 -12.57%
Sep 30, 2022 -35.10%
Jun 30, 2022 28.27%
Mar 31, 2022 -56.58%
Dec 31, 2021 -39.21%
Sep 30, 2021 28.26%